AstraZeneca vaccine: 25 more reports of blood clots but MHRA says ‘benefits outweigh risk’

Gibraltar residents discuss coronavirus vaccine rollout success

When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.

A total of 18.2 million doses of the Covid AstraZeneca vaccine were given up to March 24; in the same time period, there have been 30 blood clots cases in total. Here is the Medicines and Healthcare products Regulatory Agency (MHRA) response. “Our rigorous review into the UK reports of rare and specific types of blood clots is ongoing,” said the MHRA. There have been 22 report of “cerebral venous sinus thrombosis (CVST)” and eight reports of “other thrombosis events with low platelets”.

To date, there has been no blood clots associated with the Pfizer-BioNTech vaccine.

“On the basis of this ongoing review, the benefits of the vaccines against COVID-19 continue to outweigh any risks,” said the MHRA.

It added: “You should continue to get your vaccine when invited to do so.”

This is a breaking news story with more details to follow…

Third vaccine: Matt Hancock says Britain now working on ‘third jab’ [REPORT]
Covid symptoms: Scientists suggest hearing loss linked to virus [STUDY]
AstraZeneca vaccine headache: What causes Covid vaccine headache? [INSIGHT]

Source: Read Full Article